159 related articles for article (PubMed ID: 2055812)
1. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.
Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Humbert G
Antimicrob Agents Chemother; 1992 Dec; 36(12):2794-8. PubMed ID: 1482147
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men.
Ljungberg B; Nilsson-Ehle I
Antimicrob Agents Chemother; 1992 Jul; 36(7):1437-40. PubMed ID: 1510440
[TBL] [Abstract][Full Text] [Related]
5. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H
Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of imipenem in healthy volunteers.
Norrby SR; Björnegård B; Ferber F; Jones KH
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():109-24. PubMed ID: 6583194
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients.
Moon YS; Chung KC; Gill MA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S249-55. PubMed ID: 9126700
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of meropenem in subjects with renal insufficiency.
Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
[TBL] [Abstract][Full Text] [Related]
11. Meropenem clinical pharmacokinetics.
Mouton JW; van den Anker JN
Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.
Kelly HC; Hutchison M; Haworth SJ
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():35-41. PubMed ID: 8543497
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
Christensson BA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Oqvist B; Norrby SR
Antimicrob Agents Chemother; 1992 Jul; 36(7):1532-7. PubMed ID: 1510451
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
[TBL] [Abstract][Full Text] [Related]
15. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
Norrby SR; Rogers JD; Ferber F; Jones KH; Zacchei AG; Weidner LL; Demetriades JL; Gravallese DA; Hsieh JY
Antimicrob Agents Chemother; 1984 Nov; 26(5):707-14. PubMed ID: 6595962
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR
Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639
[TBL] [Abstract][Full Text] [Related]
20. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
Tonelli F
Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
